[
  {
    "ts": null,
    "headline": "Renewed Growth Cycle Drives a Favorable Sentiment Towards Edwards Lifesciences (EW)",
    "summary": "Edwards Lifesciences (NYSE:EW) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds. On January 20, Adam Maeder from Piper Sandler maintained his Overweight rating on Edwards Lifesciences (NYSE:EW). The analyst also adjusted his price target on the stock from $95 to $98, which now yields almost 20% upside. […]",
    "url": "https://finnhub.io/api/news?id=6ebd6082219b4f0a84e6b56ddb0cd9e98ae07d4d6eeb4eb107245c99efa3fb8d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769801493,
      "headline": "Renewed Growth Cycle Drives a Favorable Sentiment Towards Edwards Lifesciences (EW)",
      "id": 138309020,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Edwards Lifesciences (NYSE:EW) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds. On January 20, Adam Maeder from Piper Sandler maintained his Overweight rating on Edwards Lifesciences (NYSE:EW). The analyst also adjusted his price target on the stock from $95 to $98, which now yields almost 20% upside. […]",
      "url": "https://finnhub.io/api/news?id=6ebd6082219b4f0a84e6b56ddb0cd9e98ae07d4d6eeb4eb107245c99efa3fb8d"
    }
  }
]